Fact checked by Jennifer Klump Ohtuvayre (ensifentrine), a drug approved in 2024 to treat chronic obstructive pulmonary ...

In 2024, drugmakers delivered breakthrough treatments in conditions that had ... while Verona’s dual-action treatment for COPD offers a breakthrough in maintenance therapy that will help some ...

You have full access to this article via your institution. Available treatments for COPD are mainly palliative, and there are no therapies available that halt the decline in lung function or the ...

COPD treatment goal is to help you breathe easier and help regular activities. Medications along with lifestyle approaches can help. When you have COPD, medications can go a long way to help you ...

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

Struggling to manage hip pain due to arthritis, columnist Caroline Gainer recognizes she also needs help coping with ...

Current drug treatments have been incorporated into clinical practice guidelines, such as the NAEPP EPR-3 for asthma [101] and GOLD treatment guidelines for COPD, [102] both of which recognize the ...

The CRYSTAL trial is the first large-scale study exploring the effects of directly switching symptomatic, non-frequently exacerbating patients with moderate COPD from their current treatments.

and behaviors with regards to both disease and treatment were found to be more powerful predictors of medication adherence than sociodemographic and clinical factors in patients with COPD.

The global chronic obstructive pulmonary disease market size is calculated at USD 23.55 billion in 2025 and is expected to reach around USD 34.76 billion by 2 ...

The CRYSTAL trial is the first large-scale study exploring the effects of directly switching symptomatic, non-frequently exacerbating patients with moderate COPD from their current treatments.